Compare ABRDN Physical Gold Shares ETF (SGOL) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ABRDN Physical Gold Shares ETF vs Tempus AI — how do they compare? ABRDN Physical Gold Shares ETF trades at $39.92 (market cap $7.03B), while Tempus AI trades at $70.19 (market cap $12.77B). The key difference: Tempus AI is the larger of the two by market cap, and Tempus AI is trading nearer its 52-week high, ABRDN Physical Gold Shares ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ABRDN Physical Gold Shares ETF for 57 Days and Tempus AI for 22 Days on average.
| SGOL | TEM | |
|---|---|---|
Market Cap | $7.03B | $12.77B |
Volume | 2,616,502 | 8,980,490 |
Sector | Commodities - Metals/Agriculture | Broad Market / Factor |
52-Week High | $51.41 | $99.28 |
52-Week Low | $37.54 | $41.55 |
Typical Hold Time | 57 Days | 22 Days |
Enterprise Value | — | $13.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SGOL is currently trading at $39.02, down 1.66% over the past 24 hours amid broader gold market weakness. Technical indicators show a bearish trend with moving averages and oscillators signaling selling pressure. The stock faces headwinds from rising Treasury yields and Federal Reserve rate uncertainty, though some support exists at current price levels. Recent news highlights gold's sensitivity to inflation data and monetary policy expectations.
The outlook for SGOL remains challenged by macroeconomic pressures, with gold prices facing resistance from higher interest rates and dollar strength. However, potential catalysts include geopolitical tensions and any dovish shift in Fed policy. Investors should monitor inflation trends and central bank guidance for directional cues in the gold market.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ABRDN Physical Gold Shares ETF
SGOL is an ETF that is designed to track the performance of the price of gold bullion. The fund is backed by physical gold held in secured vaults, which is allocated to the ETF's custodian account. By providing direct ownership of gold without the need for physical storage or insurance, SGOL offers investors a convenient and cost-effective way to gain exposure to the gold market.
Read more on SGOL →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
